A collaborative multidisciplinary team of researchers from the Perelman School of Medicine and New York University has developed a miniature chip that could transform how blood cancer treatments are tested and tailored for patients. “This device addresses a significant gap in preclinical research, offering an advanced tool for studying CAR T cell therapy’s dynamic and multifaceted responses to leukemia,” says Saba Ghassemi of the Perelman School of Medicine at the Unviersity of Pennsylvania.

In animal studies, brain tumors nearly disappeared when an experimental drug, MT-125, was given as a combo with an oncology drug that otherwise does not work on aggressive glioblastoma. The U.S. Food and Drug Administration has given MT-125 investigational new drug status, greenlighting clinical trials.

Imagine a tool to measure how fast you’re aging… while you’re still reasonably healthy. From a single MRI of your head, researchers can measure your aging rate and predict your risk of dementia and disability years into the future, while you might still have a shot at improving your health.